Since CCL4 is a chemoattractant for the recruitment of immune cells with potential anti-tumoral activity such as NK and “naïve” T-cells, the decrease in CCL4 translates into a reduction of T-cell proliferation, activation, and infiltration into the tumor. The gene discussed is CCL4; the disease is neoplasm.